Position in RLMD
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$4,264,366
+$3,671,159 QoQ
Shares Held
616,238
+134.8% QoQ
Ownership
0.578%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#34
of 126 holders
Holding Since
Dec 2021
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLMD Over Time
Shares Held
Position Value (USD)
Derivatives in RLMD
reported options exposure · as of Sep 30, 2022CallValue
$7,404
CallShares
200
PutValue
$2,757,990
PutShares
74,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Walleye Capital LLC holds $328,656,270 across 126 Biotechnology names. RLMD ranks #25 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
126,005 | $33,608,053 | |
| 2 | CYTK |
Cytokinetics Inc
|
239,728 | $20,422,428 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
288,233 | $16,492,692 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
386,183 | $14,393,040 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,596 | $14,089,509 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
334,854 | $11,180,775 | |
| 7 | TYRA |
Tyra Biosciences, Inc.
|
347,898 | $11,111,862 | |
| 8 | BCAX |
Bicara Therapeutics Inc.
|
353,226 | $10,487,279 |
All Filings in RLMD
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,264,366 | 616,238 | Shares | Sole | 2026-08-03 | |
| 2023-03-31 | $593,207 | 262,481 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,653,153 | 473,683 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,757,990 | 74,500 | Put | Sole | 2022-11-14 | |
| 2022-09-30 | $7,404 | 200 | Call | Sole | 2022-11-14 | |
| 2022-06-30 | $2,020,915 | 106,420 | Shares | Sole | 2022-08-19 | |
| 2022-03-31 | $3,325,950 | 123,229 | Shares | Sole | 2022-05-27 | |
| 2021-12-31 | $469,052 | 20,819 | Shares | Sole | 2022-05-27 | |
| No filing history on record for this holder in this stock. | ||||||